.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
The Tablet is stocked at 215 licensed dispensaries across California, with the deepest coverage in Sacramento, San Diego, Los Angeles, San Francisco, and San Jose. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, The Tablet operated as a single-category brand with Capsules at 100.0% of mix, posting 30.27% year-over-year sales growth alongside an 11.12% month-over-month lift, while average price declined 19.87% YoY to $32.25. Within California Capsules, the brand held rank 7, indicating middle-tier placement despite the double-digit MoM gain and full category concentration; the pairing of rising volumes with a near-20% price compression implies elastic demand at lower price points and a trade-up in unit velocity rather than assortment expansion.
The combination of a 30.27% YoY sales increase and a 19.87% YoY price decline suggests The Tablet is prioritizing share capture via pricing, which aligns with the 11.12% MoM uptick and rank 7 position in California Capsules. With 100.0% of revenue in Capsules and no cross-category hedge, the pattern implies a positioning bet on cost-accessible formats to move rank upward from 7 through volume-led gains rather than premiumization or diversification.
Competitive Landscape
The Tablet ranks #7 in CA Capsules in September 2026, unchanged year over year from #7 and flat versus three months prior at #7, while category leaders moved materially: Emerald Bay Extracts climbed from #6 to #1 with 109.3% YoY sales growth and Buddies rose from #5 to #3 with 39.1% YoY growth, whereas Level fell from #1 to #4 alongside a 50.3% YoY sales decline and ABX / AbsoluteXtracts slipped from #3 to #5 amid a 32.7% drop; in this context, The Tablet’s static #7 rank and zero rank change YoY indicate share is being neither won from decliners nor captured alongside climbers, implying a stalled trajectory that risks entrenchment below the top 5 unless a catalyst shifts velocity.
Notable Products
Hybrid High Dose Tablets 50-Pack (1000mg) posted the steepest movement in September 2026 with a -50.98% month-over-month drop and slid to rank 7, indicating a sharp pullback in high-dose hybrid demand. In contrast, Sativa Tablets 20-Pack (1000mg) rose 18.25% MoM to hold rank 1 while Indica High Dose Tablets 50-Pack (1000mg) fell -11.16% MoM at rank 3, and five of the top seven SKUs are Capsules, concentrating category share at the very top. The mix of gains in standard 20-packs (+24.28% for Indica 20-Pack and +25.99% for Hybrid 20-Pack) alongside a double-digit decline in an equivalent 50-pack signals consumers shifting toward smaller-count formats within Capsules.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
